Nadifloxacin is a bacterial DNA gyrase inhibitor used to treat acne vulgaris. It inhibits Proponibacterium-stimulated cytokine expression and decreases production of oxidative radicals by neutrophils. References: Narayanan V, Motlekar S, Kadhe G, Bhagat S. Efficacy and safety of nadifloxacin for bacterial skin infections: results from clinical and post-marketing studies. Dermatol Ther (Heidelb). 2014 Dec;4(2):233-48. doi: 10.1007/s13555-014-0062-1. Epub 2014 Sep 12. PubMed PMID: 25212256; PubMed Central PMCID: PMC4257952.

纯度：≥98%

CAS：124858-35-1